Endogenous ADAM10 mRNA levels and the ADAM10 promoter activities were increased on RA treatment in neuroblastoma cells: thus, retinoic acid works as an activator of the α-secretase [49-51]. This evidence concerns the gene ADAM10 and neuroblastoma.